Market Tracker

04/17 6:05pm ET

Seattle Genetics Inc (NASDAQ:SGEN)

38.84
Data as of Apr 17
 +0.27 / +0.70%
Today’s Change
28.15
Today|||52-Week Range
55.99
-2.63%
Year-to-Date

Today’s Trading

Previous close38.57
Today’s open38.42
Day’s range38.00 - 40.24
Volume1,319,190
Average volume (3 months)1,193,240
Market cap$4.8B
Dividend yield--
Data as of 4:00pm ET, 04/17/2014

Growth & Valuation

Earnings growth (last year)-10.87%
Earnings growth (this year)-87.49%
Earnings growth (next 5 years)-28.70%
Revenue growth (last year)+27.73%
P/E ratioNM
Price/Sales18.01
Price/Book20.97

Competitors

 Today’s
change
Today’s
% change
UTHRUnited Therapeutics ...-2.02-2.06%
TAROTaro Pharmaceutical ...+1.55+1.48%
QCORQuestcor Pharmaceuti...-1.51-1.92%
MDVNMedivation Inc-0.91-1.55%
Data as of 4:04pm ET, 04/17/2014

Financials

Next reporting dateMay 2, 2014
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$269.3M
Annual profit (last year)-$62.5M
Net profit margin-23.22%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Clay B. Siegall
Chief Operating Officer &
Secretary
Eric L. Dobmeier
Corporate headquarters
Bothell, Washington

Forecasts